Autor(es): Leite, Laura Hévila Inocêncio ; Leite, Gerlânia de Oliveira ; Coutinho, Thales Silva ; Sousa, Severino Denício Gonçalves de ; Sampaio, Renata Souza ; Costa, José GalbertoMartins da ; Menezes, Irwin Rose Alencar de ; Campos, Adriana Rolim
Data: 2014
Origem: Oasisbr
Assunto(s): Dor Aguda; Medição da Dor
This study aimed to assess the possible topical antinociceptive activity of Vanillosmopsis arborea Baker essential oil (EOVA) and to clarify the underlying mechanism, using the acute model of chemical (eye wiping) nociception in mice. EOVA (25 to 200mg/kg; p.o. and topical) evidenced significant antinociception against chemogenic pain in the test model of formalin-induced neuroinflammatory pain. Local application of 5MNaCl solution on the corneal surface of the eye produced a significant nociceptive behavior, characterized by eyewiping.Thenumber of eyewipes was counted during the first 30 s. EOVA(25, 50, 100, and 200mg/kg; p.o. and topical) significantly decreased the number of eye wipes. Naloxone, yohimbine, L-NAME, theophylline, glibenclamide, and ruthenium red had no effect on the antinociceptive effect of EOVA. However, ondansetron, p-chlorophenylalanine methyl ester (PCPA), capsazepine, prazosin, and atropine prevented the antinociception induced by EOVA. These results indicate the topical antinociceptive effect of EOVA and showed that 5-HT, 1, TRPV1, and central muscarinic receptors might be involved in the antinociceptive effect of EOVA in the acute corneal model of pain in mice.
